MOLKENTIN MICHAEL 4
4 · Astex Pharmaceuticals, Inc · Filed Apr 12, 2013
Insider Transaction Report
Form 4
MOLKENTIN MICHAEL
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2013-04-10$1.65/sh+7,500$12,375→ 26,495 total - Exercise/Conversion
Employee Stock Option (Right to buy)
2013-04-10−7,500→ 67,500 totalExercise: $1.65Exp: 2019-03-12→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]The Reporting Person exercised 7,500 of the 80,000 share option granted March 12, 2009. The option vested at the rate of 1/48th of the shares on April 12, 2009 and at the end of each full month thereafter.
- [F2]Includes 3,000 shares acquired under the Issuer's 2008 Employee Stock Purchase Plan.